FluoroPharma Medical, Inc. (FPMI) Expands Technology Platform to Include Agents for Alzheimer's Disease (AD)
FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced that it has…